Chronic Heart Failure Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Ventricular Assist Devices (VADs), Implantable Cardioverter Defibrillators (ICD), Pacemakers, Cardiac Resynchronization Therapy, Counter Pulsation Devices); End User (Hospitals, Specialized Cardiovascular Disease Treatment Centers, Ambulatory Surgical Centers), and geography
Report Code: TIPRE00018030 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Heart failure (HF) is a disorder with a high level of mortality and morbidity. With a rising elderly population, its prevalence is increasing. Heart failure is treated with medical therapy using a tiered strategy due to decreased left ventricular ejection fraction. To keep the heart beating at a regular rate, a cardiac device is used. Several types of devices are available. If the patient has reduced ejection fraction (HF-rEF) heart failure and requires a device, the doctor can help to figure out what sort of device is suitable for the patient's needs.
MARKET DYNAMICS
Factors driving the growth of the chronic heart failure treatment market are the growing prevalence of cardiovascular diseases (CVD), coupled with increasing technological advanced products. However, the high cost of devices and stringent regulation and approval is expected to hamper the growth of the market. Moreover, favorable reimbursement policies and rising geriatric population is anticipated to boost the market growth.
MARKET SCOPE
The "Chronic Heart Failure Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of chronic heart failure devices market with detailed market segmentation by product type and end user. The chronic heart failure devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in chronic heart failure devices market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The chronic heart failure devices market is segmented on the basis of product type and end user. Based on product type, the market is segmented as Ventricular Assist Devices (VADs), Implantable Cardioverter Defibrillators (ICD), Pacemakers, cardiac resynchronization therapy, and counter pulsation devices. Implantable Cardioverter Defibrillators (ICD) is sub segmented as Subcutaneous ICD and Transvenous ICD. Pacemakers is sub segmented as external and implantable. Cardiac resynchronization therapy is sub segmented as Cardiac Resynchronization Therapy-Pacemakers (CRT-P) and Cardiac Resynchronization Therapy-Defibrillators (CRT-D). On the basis of raw material, the market is as hospitals, specialized cardiovascular disease treatment centers, and ambulatory surgical centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the chronic heart failure devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chronic heart failure devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting chronic heart failure devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chronic heart failure devices market in these regions.
The report covers key developments in the chronic heart failure devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from chronic heart failure devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for chronic heart failure devices in the global market. Below mentioned is the list of few companies engaged in the chronic heart failure devices market.
The report also includes the profiles of key players in chronic heart failure devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Heart failure (HF) is a disorder with a high level of mortality and morbidity. With a rising elderly population, its prevalence is increasing. Heart failure is treated with medical therapy using a tiered strategy due to decreased left ventricular ejection fraction. To keep the heart beating at a regular rate, a cardiac device is used. Several types of devices are available. If the patient has reduced ejection fraction (HF-rEF) heart failure and requires a device, the doctor can help to figure out what sort of device is suitable for the patient's needs.
MARKET DYNAMICS
Factors driving the growth of the chronic heart failure treatment market are the growing prevalence of cardiovascular diseases (CVD), coupled with increasing technological advanced products. However, the high cost of devices and stringent regulation and approval is expected to hamper the growth of the market. Moreover, favorable reimbursement policies and rising geriatric population is anticipated to boost the market growth.
MARKET SCOPE
The "Chronic Heart Failure Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of chronic heart failure devices market with detailed market segmentation by product type and end user. The chronic heart failure devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in chronic heart failure devices market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The chronic heart failure devices market is segmented on the basis of product type and end user. Based on product type, the market is segmented as Ventricular Assist Devices (VADs), Implantable Cardioverter Defibrillators (ICD), Pacemakers, cardiac resynchronization therapy, and counter pulsation devices. Implantable Cardioverter Defibrillators (ICD) is sub segmented as Subcutaneous ICD and Transvenous ICD. Pacemakers is sub segmented as external and implantable. Cardiac resynchronization therapy is sub segmented as Cardiac Resynchronization Therapy-Pacemakers (CRT-P) and Cardiac Resynchronization Therapy-Defibrillators (CRT-D). On the basis of raw material, the market is as hospitals, specialized cardiovascular disease treatment centers, and ambulatory surgical centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the chronic heart failure devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chronic heart failure devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting chronic heart failure devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chronic heart failure devices market in these regions.
The report covers key developments in the chronic heart failure devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from chronic heart failure devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for chronic heart failure devices in the global market. Below mentioned is the list of few companies engaged in the chronic heart failure devices market.
The report also includes the profiles of key players in chronic heart failure devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Boston Scientific Corporation
- Medtronic PLC
- Abiomed, Inc.
- HeartWare International, Inc.
- Jarvik Heart, Inc.
- LivaNova PLC
- ReliantHeart Inc.
- Biotronik SE & Co., KG
- Jude Medical
- Berlin Heart Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies
1. Boston Scientific Corporation
2. Medtronic PLC
3. Abiomed, Inc.
4. HeartWare International, Inc.
5. Jarvik Heart, Inc.
6. LivaNova PLC
7. ReliantHeart Inc.
8. Biotronik SE & Co., KG
9. Jude Medical
10. Berlin Heart Inc.
1. Boston Scientific Corporation
2. Medtronic PLC
3. Abiomed, Inc.
4. HeartWare International, Inc.
5. Jarvik Heart, Inc.
6. LivaNova PLC
7. ReliantHeart Inc.
8. Biotronik SE & Co., KG
9. Jude Medical
10. Berlin Heart Inc.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount